Murine models of arrhythmogenic cardiomyopathy benefit from GSK3β inhibition

(Journal of Clinical Investigation) In this issue of JCI Insight, investigators led by Jeffrey Saffitz of Harvard Medical School and Daniel Judge of John's Hopkins School of Medicine show that the GSK3β inhibitor SB2 benefits two murine models of arrhythmogenic cardiomyopathy.
Source: EurekAlert! - Biology - Category: Biology Source Type: news